Συντονιστές
Add to agenda
Presentations
PROGNOSTIC SIGNIFICANCE OF SHP2 EXPRESSION IN NON-SMALL LUNG CANCER PATIENTS
CONCOMITANT CAUSES OF ANAEMIA IN A PATIENT WITH LUNG ADENOCARCINOMA UNDER anti-PD-1 IMMUNOTHERAPY
DISTINCT PROFILE OF PROLIFERATING CD8+/TCF1+ T CELLS AMONG DIFFERENT BREAST CANCER MOLECULAR SUBTYPES
Fc ENGINEERED MONOCLONAL ANTIBODIES FOR TRIPLE NEGATIVE BREAST CANCER THERAPY
EFFECT OF THE MEK INHIBITOR COBIMETINIB ON BRAF V600E MUTATED THYROID CARCINOMA
